CD8A and neoplasm: Intriguingly, the expression of RGMb was markedly increased in tumor‐infiltrating CD8+ T cells, but not other immune cells, in anti‐tumor immune responses resistance mice, and its anti‐tumor effect was confirmed by conditional knockout of RGMb in T cells.